GKOS
Glaukos Corporation
NYSE · Healthcare · Medical - Devices · US
$177.47
−1.60%Forward multiples
Based on analyst estimates
- P/E forward
- 1158.10x
- P/E 2026E
- —
- P/E 2027E
- 349.39x
- P/E 2028E
- 107.51x
- P/S forward
- 13.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.34x
- Price / sales
- 17.08x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $10.3B
- EV / sales
- 16.78x
- EV / EBITDA
- -72.29x
- EV / EBIT
- -127.78x
- Market cap
- $10.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026